肝素钙、酚妥拉明和多巴胺联用治疗重症肺心病并呼吸衰竭的临床观察

Heparin, Phentolamine and Dopamine Combined with Clinical Observation of Treatment of Severe Pulmonary Heart Disease and Respiratory Failure

目的探讨肝素钙、酚妥拉明和多巴胺联用治疗重症肺心病并呼吸衰竭的临床效果。方法选取2013年1月至2015年1月在我院住院的102例重症肺心病并发呼吸衰竭患者作为探讨对象,根据治疗方式的不同将其分为对照组和研究组,对照组患者肝素钙治疗,研究组患者予以肝素钙、酚妥拉明和多巴胺联用治疗,并比较两组患者临床治疗效果以及不良反应发生率。结果研究组患者临床治疗总有效率为94.6%,对照组患者临床治疗总有效率为71.7%,两组比较差异具有统计学意义(P<0.05);研究组患者不良反应发生率与对照组比较差异无统计学意义(P>0.05)。结论对重症肺心病并发呼吸衰竭患者在常规治疗基础上采用肝素钙、酚妥拉明和多巴胺联用治疗其临床效果明显,且不良反应轻微,该方法值得推广应用。

Objective Discussion heparin,phentolamine and dopamine associated with the treatment of severe pulmonary heart disease and respiratory failure clinical results.Methods Select January2013-January2015in our hospital102cases of severe pulmonary heart disease patients with respiratory failure as explore objects,depending on the treatment will be divided into a control group and study group,heparin calcium in the treatment of patients in the control group,study group of patients to be heparin,phentolamine and dopamine combined with treatment,and were compared clinical outcomes and incidence of adverse reactions.Results Clinical study in patients total effective rate was94.6%,the clinical treatment of patients in the control group total effective rate was71.7%,the difference was statistically significant(P<0.05);the study group the incidence of adverse reactions in patients with the control group,the difference no statistically significant(P>0.05).Conclusion Severe pulmonary heart disease and respiratory failure in patients with heparin basis of conventional therapy,phentolamine and dopamine on patients with the clinical effect is obvious,and the adverse reactions were mild,which should be widely applied.